BlackRock Institutional Trust’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $13.1M | Sell |
407,541
-34,298
| -8% | -$1.1M | ﹤0.01% | 2240 |
|
|
2016
Q3 | $22.1M | Buy |
441,839
+57,001
| +15% | +$2.85M | ﹤0.01% | 1823 |
|
|
2016
Q2 | $16.3M | Buy |
384,838
+23,615
| +7% | +$1M | ﹤0.01% | 1977 |
|
|
2016
Q1 | $23.8M | Sell |
361,223
-7,888
| -2% | -$519K | ﹤0.01% | 1696 |
|
|
2015
Q4 | $22.9M | Buy |
369,111
+40,943
| +12% | +$2.54M | ﹤0.01% | 1764 |
|
|
2015
Q3 | $22M | Buy |
328,168
+33,022
| +11% | +$2.21M | ﹤0.01% | 1775 |
|
|
2015
Q2 | $28.7M | Sell |
295,146
-12,431
| -4% | -$1.21M | ﹤0.01% | 1669 |
|
|
2015
Q1 | $28.7M | Buy |
307,577
+73,796
| +32% | +$6.9M | ﹤0.01% | 1703 |
|
|
2014
Q4 | $20.8M | Buy |
233,781
+90,593
| +63% | +$8.05M | ﹤0.01% | 1874 |
|
|
2014
Q3 | $9.89M | Sell |
143,188
-10,525
| -7% | -$727K | ﹤0.01% | 2350 |
|
|
2014
Q2 | $8.82M | Sell |
153,713
-1,242
| -0.8% | -$71.2K | ﹤0.01% | 2507 |
|
|
2014
Q1 | $6.15M | Buy |
154,955
+3,460
| +2% | +$137K | ﹤0.01% | 2700 |
|
|
2013
Q4 | $6.35M | Sell |
151,495
-5,355
| -3% | -$225K | ﹤0.01% | 2674 |
|
|
2013
Q3 | $4.68M | Sell |
156,850
-15,549
| -9% | -$464K | ﹤0.01% | 2767 |
|
|
2013
Q2 | $9.14M | Buy |
+172,399
| New | +$9.14M | ﹤0.01% | 2369 |
|